STAT3-IN-15 is a potent and orally active STAT3 inhibitor against idiopathic pulmonary fibrosis (IPF). STAT3-IN-15 inhibits STAT3 phosphorylation. STAT3-IN-15 also inhibits the migration and deformation of epithelial cells induced by TGF-beta1 and inhibit epithelial-mesenchymal transition (EMT)[1].
Molecular Weight:
422.42
Purity:
98.99
Formula:
C20H17F3N2O3S
Target:
STAT
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted